- Trials with a EudraCT protocol (1,970)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,970 result(s) found for: Rate ratio.
Displaying page 1 of 99.
EudraCT Number: 2013-004527-36 | Sponsor Protocol Number: PILOT_EGP | Start Date*: 2014-01-10 |
Sponsor Name:Medizinische Universität Graz / Endokrinologie und Stoffwechsel | ||
Full Title: An open, non-randomized, single-center pilotstudy investigating the feasibility of determining the endogenous glucose production during a hypoglycaemic clamp in type 1 diabetes mellitus subjects | ||
Medical condition: Diabetes Mellitus Type 1 | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-006055-33 | Sponsor Protocol Number: HypoGI | Start Date*: 2023-03-05 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Assessing the feasibility of pharmacologically induced hypothyroidism in patients with advanced pancreatic cancer - a pilot study | ||
Medical condition: Patients with newly diagnosed metastatic pancreatic cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001107-27 | Sponsor Protocol Number: SI0207 | Start Date*: 2010-05-07 |
Sponsor Name:Universität Leipzig | ||
Full Title: PHASE I-II MULTICENTER STUDY OF P210-B2A2 DERIVED PEPTIDE VACCINE IN CHRONIC MYELOID LEUKEMIA PATIENTS IN COMPLETE CYTOGENETIC RESPONSE WITH PERSISTENT MOLECULAR RESIDUAL DISEASE DURING IMATINIB TR... | ||
Medical condition: Chronic myeloid leukemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002365-35 | Sponsor Protocol Number: GC1008FSGS03110 | Start Date*: 2013-07-15 | |||||||||||
Sponsor Name:Genzyme Corporation | |||||||||||||
Full Title: A Phase 2, Multicenter, Double-Blind, Parallel Dosing, Randomized Study of Fresolimumab or Placebo in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis | |||||||||||||
Medical condition: Focal segmental glomerulosclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006120-20 | Sponsor Protocol Number: 31-06-2011 | Start Date*: 2012-03-15 |
Sponsor Name:University Medical Centre Ljubljana | ||
Full Title: Efficacy and safety of selective vitamin D receptor activation with paricalcitol for reduction of proteinuria in kidney transplant recipients: a randomized controlled trial | ||
Medical condition: Proteinuria in kidney transplant recipients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000194-93 | Sponsor Protocol Number: ENTRAP | Start Date*: 2021-12-22 |
Sponsor Name:Radboud University Medical Center | ||
Full Title: Exendin PET/CT for imaging of paragangliomas | ||
Medical condition: Paraganglioma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004578-40 | Sponsor Protocol Number: SSAT066 | Start Date*: 2015-01-26 |
Sponsor Name:St Stephen's AIDS Trust | ||
Full Title: A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal ... | ||
Medical condition: HIV | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-000199-41 | Sponsor Protocol Number: GESIDA10918 | Start Date*: 2019-07-10 | |||||||||||
Sponsor Name:Fundación SEIMC-GESIDA | |||||||||||||
Full Title: A phase IV, multicenter, open and randomized study to evaluate the impact of the change of antiretroviral treatment from dual therapy to triple therapy on inflammation in patients with type 1 HIV i... | |||||||||||||
Medical condition: HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005315-18 | Sponsor Protocol Number: HMX3501 | Start Date*: 2009-07-21 | ||||||||||||||||
Sponsor Name:Mundipharma Research GmbH & Co. KG | ||||||||||||||||||
Full Title: A confirmatory, placebo-controlled, randomised, double-blind, single-dummy, parallel group, ratio-finding study in constipated pain patients to establish an optimal hydromorphone – naloxone ratio w... | ||||||||||||||||||
Medical condition: Moderate to severe chronic non-cancer or cancer pain with opioid induced constipation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) FI (Completed) GB (Completed) FR (Completed) NL (Completed) DE (Completed) AT (Completed) BE (Completed) DK (Completed) RO (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-003280-26 | Sponsor Protocol Number: IMB101-005 | Start Date*: 2020-11-09 | |||||||||||
Sponsor Name:Imbria Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Dose-Ranging Pharmacodynamic Study to Evaluate the Effects of IMB-1018972 on Myocardial Energetics, Metabolism, and Function in Patients with Type 2 Diabetes | |||||||||||||
Medical condition: Diabetic Cardiomyopathy (DbCM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000811-26 | Sponsor Protocol Number: STOPPRE | Start Date*: 2018-09-19 | |||||||||||
Sponsor Name:Vall D'Hebron Institut de Recerca (VHIR) | |||||||||||||
Full Title: A phase III, multicentric, Randomized, open-label, parallel-group clinical trial to detect false positives from first-trimester preeclampsia screening (StopPRE) at the second-trimester of pregnancy. | |||||||||||||
Medical condition: First-trimester pre-eclampsia patients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003577-25 | Sponsor Protocol Number: 1907V921F | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Shionogi B.V. | |||||||||||||
Full Title: A Phase 1/2, Multicentre, Open-label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Naldemedine in Paediatric Patients Who Are Receiving or Who Are About to Receive Treatment w... | |||||||||||||
Medical condition: Opioid induced constipation | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Completed) HU (Prematurely Ended) IT (Completed) NL (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000891-27 | Sponsor Protocol Number: CLNP023X2203 | Start Date*: 2017-11-21 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients | |||||||||||||
Medical condition: Primary IgA Nephropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) SE (Completed) FI (Completed) DE (Completed) BE (Completed) NL (Completed) DK (Completed) CZ (Completed) HU (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002594-28 | Sponsor Protocol Number: APHP200036 | Start Date*: 2022-10-05 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Graft Acute kidney injury: vitamin B3 to facilitate renal Recovery In the Early Life of a transplant | |||||||||||||
Medical condition: Patients with end-stage renal failure treated with extrarenal purification (hemodialysis using a catheter or a fistula, or peritoneal dialysis), registered on the national kidney donation waiting l... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004455-35 | Sponsor Protocol Number: Abscess-Cef-Moxi | Start Date*: 2005-11-22 |
Sponsor Name:Department of Clinical Pharmacology, Medical University of Vienna | ||
Full Title: Plasma and abscess fluid pharmacokinetics of cefpirome and moxifloxacin after single dose and multiple dose administration | ||
Medical condition: Abscess or abdominal cyst | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001541-39 | Sponsor Protocol Number: BEVACOR | Start Date*: 2020-04-24 | ||||||||||||||||
Sponsor Name:Fundación para la Investigación Biomédica de Córdoba | ||||||||||||||||||
Full Title: Pilot study of single-dose bevacizumab as a treatment for acute respiratory distress syndrome in patients with COVID-19 | ||||||||||||||||||
Medical condition: Acute respiratory distress syndrome in patients with COVID-19 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009599-11 | Sponsor Protocol Number: 08/0339 | Start Date*: 2011-02-15 |
Sponsor Name:Joint UCLH/UCL/Royal Free Biomedical Research Unit | ||
Full Title: Prospective randomised cross over comparison on the physiological response to non-invasive ventilation using either Air O2 or Heliox21 | ||
Medical condition: Respiratory failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-002978-13 | Sponsor Protocol Number: Verde_Nano | Start Date*: 2016-09-13 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA | |||||||||||||
Full Title: Assessment of the feasibility and clinical efficacy of the ICG - 99mTc - nanocolloid for sentinel lymph node biopsy | |||||||||||||
Medical condition: Patients with breast cancer or melanoma candidates for sentinel node biopsy surgery. The regional lymph nodes are the most common site of metastatic involvement in patients with cutaneous melanoma ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013458-33 | Sponsor Protocol Number: CCB‐KARD‐09‐01 | Start Date*: 2009-11-30 |
Sponsor Name:Charité Universitätsmedizin Berlin | ||
Full Title: Modulation of Cytochrome-P450 dependent eicosanoid formation by treatment with omega-3 PUFA (Omacor®) | ||
Medical condition: Healthy volunteers intended indication of the product: primary and secondary prevention of cardiovascular morbidity and mortality | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-002130-33 | Sponsor Protocol Number: ZILU-COV | Start Date*: 2020-05-26 |
Sponsor Name:University Hospital Ghent | ||
Full Title: A prospective, randomized, open-label, interventional study to investigate the efficacy of complement C5 inhibition with Zilucoplan® in improving oxygenation and short- and long-term outcome of COV... | ||
Medical condition: COVID-19 patients with acute hypoxic respiratory failure. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
